Your browser doesn't support javascript.
loading
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
Krug, Sebastian; Kegel, Thomas; Gress, Thomas M; Rinke, Anja; Apostolidis, Leonidas; Jann, Henning; König, Alexander; Hörsch, Dieter; Schrader, Jörg; Ettrich, Thomas J; Richter, Michael; Steighardt, Jörg; Michl, Patrick.
Affiliation
  • Krug S; Department of Internal Medicine I, Martin-Luther University Halle/Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany.
  • Kegel T; Department of Internal Medicine IV, Martin-Luther University Halle/Wittenberg, Halle, Germany.
  • Gress TM; Department of Gastroenterology, Endocrinology and Metabolism, Philipps-University Marburg, Marburg, Germany.
  • Rinke A; Department of Gastroenterology, Endocrinology and Metabolism, Philipps-University Marburg, Marburg, Germany.
  • Apostolidis L; Department of Medical Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Jann H; Department of Gastroenterology and Hepatology, Charité University Hospital, Berlin, Germany.
  • König A; Department of Gastroenterology and gastrointestinal Oncology, Georg-August University, Göttingen, Germany.
  • Hörsch D; Department of Gastroenterology/Endocrinology, Center for Neuroendocrine Tumors Bad Berka, Bad Berka, Germany.
  • Schrader J; Department of Medicine - Gastroenterology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ettrich TJ; Department of Internal Medicine I, University of Ulm, Ulm, Germany.
  • Richter M; Coordination Centre for Clinical Trials, Faculty of Medicine, Martin-Luther University Halle/Wittenberg, Halle, Germany.
  • Steighardt J; Coordination Centre for Clinical Trials, Faculty of Medicine, Martin-Luther University Halle/Wittenberg, Halle, Germany.
  • Michl P; Department of Internal Medicine I, Martin-Luther University Halle/Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany. patrick.michl@uk-halle.de.
BMC Cancer ; 21(1): 1206, 2021 Nov 12.
Article in En | MEDLINE | ID: mdl-34772353
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neuroendocrine Tumors / Angiogenesis Inhibitors / Dacarbazine / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neuroendocrine Tumors / Angiogenesis Inhibitors / Dacarbazine / Antibodies, Monoclonal, Humanized / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Germany